Clinical Indicators for Coders/CDI The following indicators, when present in physician documentation, laboratory values, or diagnostic reports, support assignment of a Crohns disease diagnosis and may trigger CDI queries for greater specificity: When imaging or operative reports document a fistula, abscess, or bowel obstruction in a patient with known Crohns disease, and the attendings Crohns diagnosis code lacks a complication specifier, query the provider: Does the patients current admission involve Crohns disease with [fistula / abscess / obstruction / rectal bleeding] as a complication of the Crohns, a separate condition, or both? This distinction determines whether to code K50.x13, K50.x14, K50.x12, or K50.x11 vs
TB500 promotes endothelial cell migration and proliferation, raises VEGF production, and supports new capillary networks
It is normal for progress to slow down
Legal risk Doctors and pharmacies can face prosecution
In contrast, the EFSA reports that a cut-off value of 750 nmol/l is used for the diagnosis of cobalamin deficiency for all ages (EFSA, 2015)
Current status As of early 2026, compounding pharmacies like Empower can continue producing semaglutide formulations that are clinically differentiated from commercially available products